Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease. | Cell Res | 2024 | 38267638 | PubTator, text mining | PubMed |
| Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology. | Acta Neuropathol | 2024 | 38265527 | PubTator, text mining | PubMed |
| Fibronectin mediates activin A-promoted human trophoblast migration and acquisition of endothelial-like phenotype. | Cell Commun Signal | 2024 | 38263146 | PubTator, text mining | PubMed |
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. | Biomedicines | 2024 | 38255305 | PubTator, text mining | PubMed |
| Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis. | Biomedicines | 2024 | 38255213 | PubTator, text mining | PubMed |
| How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva. | Biomolecules | 2024 | 38254701 | PubTator, text mining | PubMed |
| A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo. | Am J Physiol Gastrointest Liver Physiol | 2024 | 38252872 | PubTator, text mining | PubMed |
| BMP-ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B-Cell Lymphoma. | Adv Sci (Weinh) | 2024 | 38229201 | PubTator, text mining | PubMed |
| Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva. | Orthop Surg | 2024 | 38185793 | PubTator, text mining | PubMed |
| Directional Endothelial Communication by Polarized Extracellular Vesicle Release. | Circ Res | 2024 | 38174557 | PubTator, text mining | PubMed |
| PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo. | Sci Rep | 2024 | 38172189 | PubTator, text mining | PubMed |
| Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices. | Am J Hematol | 2024 | 38164985 | PubTator, text mining | PubMed |
| A fibrodysplasia ossificans progressiva patient with a rare missense mutation in ACVR1 detected on 18F-FDG PET/CT. | Joint Bone Spine | 2024 | 38159793 | PubTator, text mining | PubMed |
| Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway. | Oncol Rep | 2024 | 38131250 | PubTator, text mining | PubMed |
| TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax. | Leukemia | 2024 | 38007585 | PubTator, text mining | PubMed |
| Rare loss-of-function variants in matrisome genes are enriched in Ebstein's anomaly. | HGG Adv | 2024 | 38006208 | PubTator, text mining | PubMed |
| Corrigendum to "Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene" [Bone 138 (2020) 115469]. | Bone | 2024 | 37984130 | PubTator, text mining | PubMed |
| MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1. | Oncol Rep | 2024 | 37975233 | PubTator, text mining | PubMed |
| Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells. | Oncol Rep | 2024 | 37975230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=9